ClariVest Asset Management’s Evolent Health EVH Stock Holding History

ClariVest Asset Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$689K	Hold	36,046	–	–	0.07%	321
2024 Q2	$689K	Sell	36,046 -95	-0.3%	-$2.43K	0.07%	321
2024 Q1	$1.19M	Buy	36,141 +52	+0.1%	+$1.66K	0.12%	234
2023 Q4	$1.19M	Sell	36,089 -6,400	-15%	-$181K	0.07%	218
2023 Q3	$1.16M	Sell	42,489 -51,666	-55%	-$1.44M	0.06%	205
2023 Q2	$2.85M	Sell	94,155 -13,704	-13%	-$443K	0.14%	102
2023 Q1	$3.5M	Buy	107,859 +73	+0.1%	+$2.31K	0.16%	115
2022 Q4	$3.03M	Sell	107,786 -325	-0.3%	-$9.32K	0.15%	119
2022 Q3	$3.88M	Buy	108,111 +23,996	+29%	+$845K	0.19%	96
2022 Q2	$2.58M	Buy	+84,115	New	+$2.45M	0.11%	152

Other funds holding EVH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

ClariVest Asset Management's EVH Position: Q3 2024 in Review

ClariVest Asset Management held its Evolent Health (EVH) position steady in Q3 2024 at 36,046 shares worth $689K. The position accounts for 0.07% of the portfolio, ranked #321.

ClariVest Asset Management first reported a position in EVH in Q2 2022 and has held it in 10 quarters since. The position peaked at $3.88M in Q3 2022. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

ClariVest Asset Management held 36,046 shares of Evolent Health worth $689K as of Q3 2024.
ClariVest Asset Management left its Evolent Health share count unchanged in Q3 2024.
Evolent Health made up 0.07% of ClariVest Asset Management's portfolio in Q3 2024, its #321 holding.
ClariVest Asset Management first reported a position in Evolent Health in Q2 2022 and has held it in 10 quarters since.
ClariVest Asset Management's Evolent Health position peaked at $3.88M in Q3 2022.
262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.